New Cancer Gene Therapy Data Have Been Reported by Investigators at Sichuan University (Advances In Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia).

A recent study conducted at Sichuan University in China explores the potential of nanomedicine in the treatment of acute myeloid leukemia (AML). The researchers highlight the limitations of current therapies for AML, such as drug toxicity and resistance, and discuss the use of nanoparticles, including liposomes, polymersomes, micelles, dendrimers, and inorganic nanoparticles, as a more effective and safer approach. They also examine strategies for enhancing therapeutic targetability and the application of nanomedicine in immunotherapy. The study provides an overview of recent developments in nanomedicine for AML and discusses the advantages and challenges of this approach. [Extracted from the article]